G&M Health,LLC

A deeper dive into OIG’s new guidance and its impact on your Compliance Adherence Practices. Learn how to best leverage the OIG Compliance Guide in light of the DOJ Evaluation of Corporate Compliance Programs.

Speakers:

Frank Adamo, Former Senior Special Agent, Office of the Inspector General (OIG), Department of Justice
Robert Melillo, J.D, Managing Director- Chief Compliance Officer, G&M Health

9:00 AM – 9:45 AM
State of New Jersey Update

Do you know how the New Jersey State Price Transparency Law came about?

Join us in this interactive session led by Shabnam Salih from the Governor's Office of Health Care Affordability and Transparency in the State of New Jersey.

Speaker:

Shabnam Salih, Director, The Governor's Office of Health Care Affordability and Transparency, State of New Jersey

10:00 AM – 10:15AM
Morning Break

10:15 AM – 11:00 AM
Direct-to-Consumer Prescription Drug Advertisements

The FDA set 5 standards for what is “Clear, Conspicuous, and Neutral” for direct-to-consumer ads in a newly issued guidance, this session will educate you on all aspects of the guidance requirements to prepare for the November 2024 deadline.

Speakers:

Jane Puckett, VP of Medical Affairs, G&M Health
Alan G. Minsk, J.D., Arnall Golden Gregory LLP

11:00 AM – 11:30 AM
State Updates

Keep up with the constant changes in the state laws. This session will provide a review of the 2024 passed legislations as well as introduced proposed legislations.

Speaker:

Olivia Krzeminski, J.D, Associate Director Compliance, G&M Health

11:30 AM – 12:15 PM
Effective Communication and Collaboration between Compliance; Field Sales, Marketing and other departments

Speakers:

Elizabeth Powell, J.D, Chief Compliance Officer and Head of Legal, ANI Pharmaceuticals
Gregory Rubert, Senior Vice President Commercial Operations, Bausch Health Companies

12:30 PM – 1:30 PM
Lunch

1:30 PM – 2:15 PM
State Privacy

The CCPA changed the privacy landscape forever, with over a dozen states following suit, and many more to come. Learn the similarities and differences of these consumer data acts, and how companies are handling them.

Speakers:

David Stollman, Head of Compliance, Biocon Biologics
Thomas Daly, Associate Director Compliance, Biocon Biologics

02:15 PM – 3:00PM
State Price Transparency

About half the states require some form of drug price transparency, with each one setting their own threshold for reporting. This session will walk you through the nuances so you know when (and when not) to report.

Speakers:

Roland Hoffman, Associate Director Strategic Pricing and Contracting, IPSEN
David Savidge, Director of Accounts, G&M Health

3:00 PM – 3:20 PM
Afternoon Break

3:45 PM – 5:00 PM
Chief Compliance Officer Panel and Final Remarks

Unlock new perspectives from this session that aims to deliver excellence through shared knowledge as a panel of compliance officers discuss the hottest topics.

Speakers:

Dixon Terry, MPH, VP, Compliance, Lexicon Pharmaceuticals
Alexis Shaw, Deputy Chief Compliance Officer, Paratek
Steve Cohen, Vice President- Chief Compliance Officer, Eli Lilly and Company
Elizabeth Powell, J.D, Chief Compliance Officer and Head of Legal, ANI Pharmaceuticals
Chris Fletchall, VP of Compliance, G&M Health LLC

Moderator:

Brian Van Hoy, VP of Compliance, G&M Health LLC

G&M Conference Agenda

Conference Date: May 7, 2024

Location: Bridgewater Marriott

7:30 AM – 8:00 AM
Breakfast

8:00 AM – 8:15 AM
Conference Host Introduction

8:15 AM – 9:00 AM
OIG New General Compliance Program Guidance

Speakers:

9:00 AM – 9:45 AM
State of New Jersey Update

Speaker:

10:00 AM – 10:15AM
Morning Break

10:15 AM – 11:00 AM
Direct-to-Consumer Prescription Drug Advertisements

Speakers:

11:00 AM – 11:30 AM
State Updates

Speaker:

11:30 AM – 12:15 PM
Effective Communication and Collaboration between Compliance; Field Sales, Marketing and other departments

Speakers:

12:30 PM – 1:30 PM
Lunch

1:30 PM – 2:15 PM
State Privacy

Speakers:

02:15 PM – 3:00PM
State Price Transparency

Speakers:

3:00 PM – 3:20 PM
Afternoon Break

3:45 PM – 5:00 PM
Chief Compliance Officer Panel and Final Remarks

Speakers:

Moderator: